Cannabis Policy
Two Cannabis-based Medicines Approved in the UK
The cannabis-based drugs could help thousands of patients with epilepsy and multiple sclerosis, but campaigners say the approval doesn't go far enough.
New Trade Association Launched in the UK to Lead CBD Industry Regulation
The Association for the Cannabinoid Industry has been launched to bring together businesses and industry experts committed to “fostering a legally compliant, socially responsible and innovative CBD industry, which puts customers’ safety first.”
20,000 UK Patients To Take Part in Europe’s Largest Medical Cannabis Trial
In a bid to create the largest body of evidence on medical cannabis in Europe, up to 20,000 patients in the UK will be enrolled in a two-year-long medical cannabis project.
How To Have Your Say on the USDA’s New Hemp Rules
Last week, the US Department of Agriculture released its draft of interim regulations for the American hemp industry - and it's waiting for feedback.
“We Need To Make It Safer:” Dr Graham Wood on the Vaping Crisis
With the health and safety spotlight now firmly on vaping, Dr Graham Wood says that regulators shouldn’t miss this chance to properly assess vaping’s potential harms.
French Lawmakers Give Green Light to Two-year Medical Cannabis Trial
With funding secured, the trial is expected to begin in early 2020.
An Insider’s Look at the Canadian Cannabis Testing Industry With Kaveh Kahen
Discussing the ins and outs of Canada’s cannabis testing industry, Analytical Cannabis spoke to Dr Kaveh Kahen, CEO of Sigma Analytical Services, a Toronto-based provider of testing, research, and product development services to the cannabis industry.
CBD During Pregnancy – Many Assume It’s Safe Despite Lack of Evidence, Study Finds
While people generally understand the dangers associated with alcohol and pregnancy, they may be far less skeptical about the safety of CBD products.
If Legalized, Germany’s Recreational Cannabis Market Could Be Worth €8.5 Billion by 2028, Experts Predict
The new report also estimates that the Germany's existing medical cannabis sector could be worth €7.7 billion by the year the same year.
